Literature DB >> 3087374

Studies of chemical and biologic properties of a fraction of sulodexide, a heparin-like glycosaminoglycan.

B Radhakrishnamurthy, C Sharma, R R Bhandaru, G S Berenson, L Stanzani, R Mastacchi.   

Abstract

The chemical composition and biologic properties of a fraction (f) of Sulodexide, a heparin-like GAG, were studied and compared with those of two sulfated GAG preparations and heparin from intestinal mucosa. f-Sulodexide and the sulfated GAG preparations were fractionated on a Dowex-1Cl- column and subsequently on an antithrombin III affinity column. Low affinity and high affinity fractions had similar chemical composition and lipoprotein lipase releasing ability, but they varied in anticoagulant activity. Low affinity fractions from f-Sulodexide had negligible anticoagulant activity while high affinity fractions had one-half the activity of mucosal heparin. When compared to heparin, both fractions had one third amount of lipoprotein lipase releasing activity. The low anticoagulant activity of f-Sulodexide suggests a suitability for long-term use as an antiatherogenic agent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3087374     DOI: 10.1016/0021-9150(86)90006-7

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Effects of the oral administration of glycosaminoglycans on cellular abnormalities associated with idiopathic calcium oxalate nephrolithiasis.

Authors:  B Baggio; G Gambaro; G Marzaro; F Marchini; A Borsatti; G Crepaldi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure.

Authors:  Ping Li; Lin-lin Ma; Ru-juan Xie; Yuan-sheng Xie; Ri-bao Wei; Min Yin; Jian-zhong Wang; Xiang-mei Chen
Journal:  Acta Pharmacol Sin       Date:  2012-05       Impact factor: 6.150

Review 3.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 4.  The role of sulodexide in the treatment of diabetic nephropathy.

Authors:  Ram Weiss; Robert Niecestro; Itamar Raz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy.

Authors:  Michele Rossini; Takashi Naito; Haichun Yang; Michael Freeman; Ellen Donnert; Li-Jun Ma; Stephen R Dunn; Kumar Sharma; Agnes B Fogo
Journal:  Nephrol Dial Transplant       Date:  2010-01-07       Impact factor: 5.992

6.  Use of sulodexide in patients with peripheral vascular disease.

Authors:  J Lasierra-Cirujeda; P Coronel; Mj Aza; M Gimeno
Journal:  J Blood Med       Date:  2010-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.